This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nipro Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations by Ai Minomo in Bilirubin Excretion Enhancement
Introduction
Ai Minomo is an innovative inventor based in Kumamoto-shi, Japan. She is focused on developing novel therapies for hyperbilirubinemia, a condition characterized by elevated levels of bilirubin in the blood. Her work aims to enhance bilirubin excretion, providing potential benefits for patients suffering from this condition.
Latest Patent Applications
Ai Minomo has filed a patent application for a bilirubin excretion enhancer. The invention comprises a serum albumin domain II-like protein, which includes a serum albumin subdomain IIA as its active ingredient. In one embodiment, this subdomain has a specific amino acid sequence identified as SEQ ID NO: 1. Additionally, the serum albumin domain II-like protein may also be a serum albumin domain II, which comprises the amino acid sequence of SEQ ID NO: 4. This innovative approach could pave the way for effective treatments for hyperbilirubinemia.
Conclusion
Ai Minomo's contributions to the field of bilirubin excretion enhancement represent a significant step forward in addressing hyperbilirubinemia. Her innovative patent application showcases her commitment to improving patient outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile